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Controlled-release albendazole capsules (CRCs) are currently registered for use in Australia 
and New Zealand as anthelmintic treatment in sheep. However, reports on the efficacy of 
such  products  on  resistant  parasite  populations  are  sometimes  controversial.  This  is  the 
first study to report on the efficacy of such products under South African field conditions in 
sheep harbouring a population of Haemonchus contortus with known multiple anthelmintic 
resistance, including to albendazole. Treatment groups were comprised of CRC-treated and 
single dose albendazole-treated sheep, as well as negative controls. Groups were compared 
by using faecal egg count reduction tests, FAMACHA© anaemia scoring, conception rates and 
comparative weight gains over three and a half months. Based on a comparison of faecal egg 
counts, no advantage could be found using CRCs. Moreover, the use of the product actually 
decreased weight gain when compared with the control group animals.
Introduction
Worldwide,  anthelmintic  resistance  is  a  major  problem  in  the  livestock  industry.  Against 
this  background,  novel  compound  discovery,  combinations,  methods  of  delivery,  parasite 
management programmes and even vaccinations have been actively researched in order to make 
livestock farming more profitable, or in severe cases, even possible. In South Africa, the situation 
regarding haemonchosisis is no exception (Van Wyk & Bath 2002; Van Wyk, Malan & Randles 1997).
The controlled-release capsule (CRC) is a tool that has been developed to extend the efficacy of 
anthelmintics after treatment. Theoretically, this would lead to longer treatment intervals with 
accompanying reduced stress to animals and labour costs. The effects on resistant helminths or 
the development of resistance to such a product is less clear. Previous reports have indicated 
conflicting  results  as  to  the  efficacy  of  the  sustained-released  anthelmintics  against  resistant 
parasites (Sutherland et al. 1998). One such product registered for use in Australia and New 
Zealand  is  a  35%  m/m  albendazole  sustained-release  capsule  (Extender  100®,  Merial,  New 
Zealand)  that  can  provide  100  days  of  continuous  protection  against  susceptible  strains  of 
Haemonchus contortus (H. contortus) (according to the product’s package insert).
In this study, the authors aimed to investigate the level of efficacy of sustained-release albendazole 
capsules for the first time in South Africa. However, as opposed to the label information that 
claims efficacy against susceptible helminth populations, this product was evaluated on a field 
strain of H. contortus in which multiple anthelmintic resistance had been recognised previously. 
The aim was to establish how such a product might affect the control of resistant parasites in a 
farming situation.
Materials and methods
Experimental design and randomisation
The  trial  was  conducted  as  a  positive  and  negative  controlled  field  efficacy  study  of  CRC 
albendazole against resistant H. contortus in sheep. Faecal egg counts (FEC) were compared 
between sheep treated with Extender 100® capsules and a negative and positive control group.
On 29 March 2011, a week after the egg per gram (EPG) count on a pooled flock sample reached 
3300, treatment commenced (day 0). On this day, all animals were weighed, ranked by weight, 
and  randomly  allocated  into  treatment  groups.  Additionally,  faecal  samples  were  collected, 
FAMACHA© scores were assigned (see below) and treatment was given. 
Two hundred maiden ewes were randomly allocated into treatment, positive control and negative 
control groups by sorting them alternatively through a swing gate (Table 1). The treatment group 
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consisted of 100 animals, the negative control group of 85 
animals and the positive control group of 15 animals. In the 
treatment  group,  two  further  subgroups  were  created:  50 
animals from which individual faecal samples were collected 
and 50 animals from which only pooled faecal samples were 
used for faecal analysis. Similarly, in the control group, two 
subgroups were created by randomly assigning animals: 50 
animals from which  individual faecal  sample EPG  counts 
would be done and 35 animals that contributed to a pooled 
faecal sample for EPG counts. 
Each animal in the treatment group received a CRC (Extender 
100®, 35% m/m albendazole). The 15 positive control animals 
each received a standard oral dose (2 mL per 10 kg body 
weight) of a commercially available short-acting albendazole 
(Valbazen 1.9% m/v, Pfizer Animal Health, South Africa), 
whilst negative animals were left untreated.
Further faecal sample examination and FAMACHA© scoring 
was  done  every  14  days  throughout  the  study  until  the 
termination of the animal phase of the study on day 99 after 
treatment commenced.
Study animals
Before inclusion in the study, 200 Dohne merino ewes, which 
were 18 months of age and weighed between 35 kg and 
50 kg, were clinically examined by a veterinarian and found 
to be healthy. 
Study site
All the study animals originated from and remained on the 
same farm for the duration of the study, which is located in 
the Stutterheim area of the Eastern Cape Province of South 
Africa (32°38’00’’S and 27°35’32’’E), a high summer rainfall 
area. The animals remained in the same camp during the 
study and were thus exposed to the same natural grazing 
(mixed  sourveld)  and  parasite  burden.  In  addition,  all 
animals were exposed to the same routine procedures for the 
duration of the study, which included mating 49 days to 91 
days after commencement of the trial.
Parasite details
The H. contortus strain involved on this farm is known as 
the Stutterheim strain (also Kei road Strain or Robbie Blaine 
Strain) and has been used previously to test anthelmintics 
with an efficacy claim against resistant H. contortus (Little 
et al. 2011). In earlier trials performed on this farm during 2005 
and 2007, FEC reduction tests revealed resistance patterns 
(as summarised in Table 2). In addition, faecal cultures from 
previous  and  subsequent  trials  (performed  according  to 
Reinecke 1983) revealed that the roundworm eggs that were 
produced were 100% H. contortus (Fisher 2013).
Faecal egg counts
Faecal  processing  and  egg  counts  (modified  McMaster 
method  [Reinecke  1983])  were  performed  blindly  by 
technicians  at  the  Provincial  Veterinary  Laboratory, 
Queenstown, South Africa. For the bulk sample analyses, the 
FEC were performed three times and the average was taken.
FAMACHA©
From day 0 FAMACHA© was performed on all study animals 
approximately  every  fortnight.  FAMACHA©  is  a  method 
of selective treatment of sheep whereby only animals with 
the  conjunctival  mucous  membranes  displaying  a  certain 
degree of anaemia, as judged by a colour guide chart, are 
treated. Animals are subsequently divided into five groups 
based on their anaemia score: a score of 1 having pink-red 
mucous membrane colour and not requiring treatment for 
haemonchosis, to a score of 5 meaning that an animal has 
white  mucous  membranes,  requires  immediate  treatment 
for haemonchosis and probable intensive medical treatment 
(Bath, Malan & Van Wyk 1996; Van Wyk & Bath 2002).
Analysis of trial results
The efficacy of the treatment was calculated using arithmetic 
group means in the following formula (McKenna 2006): 
% Efficacy = 100 (1 – [Tafter/Tbefore] x [Cbefore/Cafter])         [Eqn 1]
T is the mean egg count of treated animals; before refers to 
day 0 and after to the specific day after the treatment date; C 
is the mean egg count of untreated controls.
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TABLE 2: Summary of the efficacy of various registered anthelmintics against the 
Stutterheim strain of H. contortus during 2005. 
Compounds Trade name % egg count reduction
Albendazole + Levamizole + 
Ivermectin
Triton (Merial) -31%
Albendazole + Closantel Valbantel (Pfizer) 13%
Rafoxanide Ranox (Pfizer) -40%
Morantel Banminth II (Pfizer) -37%
Levamizole Tramisol (Afrivet) 38%
Albendazole Valbazen (Pfizer) -8%
Doramectin Dectomax (Pfizer) -16%
Moxidectin† Cydectin (Pfizer) 13%
†, The moxidectin data were from a survey (A.D. Fisher, 2007 unpublished data). 
Note: Minus scores indicate that the faecal egg counts actually rose by that percentage in the 
faecal egg count reduction test.
TABLE 1: Summary of the study design.
Study group Sub group Treatment product Subgroup n Total n
Negative control Individual faecal samples None 50 85
Bulk faecal samples None 35 -
Positive control - Valbazen (single dose albendazole) - 15
Treated group Individual faecal samples - 50 100
Bulk faecal samples - 50 -
n, number of animalsOriginal Research
doi:10.4102/jsava.v84i1.1000 http://www.jsava.co.za
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Arithmetic means were used in the calculations of efficacy, 
as recent simulations have shown arithmetic means to give 
more accurate estimations of efficacy than logarithmic means 
(Dobson et al. 2009). FECs at different time periods were not 
compared with Repeated Measures Analysis of Variance as 
the assumption of sphericity among variances was not met. 
Thus,  the  non-parametric  Kruskal-Wallis  test  (Kruskal  & 
Wallis 1952) was performed at each time period. Proportions 
of  animals  showing  different  EPG  values  were  evaluated 
with a chi-square test for an r × k contingency table.
Results
The efficacy results are shown in Table 3. Apart from day 30 
post treatment (35.4% efficacy), there did not seem to be any 
efficacy of the product when individual animal FEC samples 
were  compared.  Furthermore,  the  Kruskal-Wallis  test 
revealed that the only significant difference in FEC between 
groups existed at day 15 after treatment (H (3) = 16.36, 
p < 0.001), at which time the single treatment albendazole 
group  had  an  efficacy  of  83.6%  (Table  3).  The  bulk  FEC 
samples revealed a slightly longer duration of effect, albeit 
not satisfactorily effective (< 90.0%). By the end of the trial, 
various animals had a zero eggs per gram faecal count: 31 
(62.0%)  in  the  individually  sampled  CRC  treated  group, 
38  (76.0%)  in  the  individually  sampled  negative  control 
subgroup and 9 (60.0%) in the positive control group. The 
zero EPG rate was independent of the treatment group that 
the animal belonged to (χ2
(2) = 2.73, p = 0.26).
None  of  the  sheep  included  in  the  study  showed  signs 
of  severe  helminthosis  requiring  anthelmintic  treatment 
according  to  the  FAMACHA©  evaluation.  The  median 
FAMACHA© scores were the same for all the groups at every 
time period measured (median = 1). Similarly, conception 
results did not differ between CRC and untreated sheep 
(χ2
(1) = 0.001, p = 0.97). However, there was a significant effect 
of  the  type  of  treatment  on  the  weight  gain  in  the  sheep 
(Table 4; F(2,196) = 7.46, p < 0.05). Multiple comparisons using 
Bonferroni adjustment revealed that the untreated control 
group had significantly higher weight gains than the group 
treated with the Extender 100® capsule. There was, however, 
no significant difference in weight gain between the negative 
(untreated) and positive (Valbazen) control groups.
Discussion
Extender 100® capsules are currently registered in Australia 
and  New  Zealand  for  treatment  against  susceptible 
populations  of  H.  contortus.  This  study  investigated  the 
efficacy of sustained- release anthelmintics on resistant H. 
contortus infections.
Contrary to what previous studies have suggested (Fisher, 
Jacobs  &  Jones  1992;  Le  Jambre  et  al.  1981),  but  similar 
to  Sutherland  et  al.  (1998),  no  advantage  was  found 
according  to  faecal  egg  counts  of  sheep  treated  with 
sustained  released  albendazole  compared  with  either 
single  treatment  albendazole  or  untreated  controls  when 
infected with resistant H. contortus. Interestingly, the short-
acting albendazole combination had reverted back to 83.6% 
effectivity (moderately effective as described by Wood et al. 
1995) from the -8.0% efficacy measured six years before the 
study. Although it is encouraging to learn the extent to which 
albendazole resistance appears to have been reversed on this 
farm, it is far less positive for the use of slow-release capsules.
Interestingly, the CRC treated sheep had a lower weight gain 
over  the  study  period  compared  with  untreated  animals, 
similar to findings of Kelly, Walkden-Brown and Kahn (2012) 
and Williamson (1995). No previous report has attempted to 
explain this effect, but it may perhaps be related to larval 
mucosal stages inhibited by sustained release albendazole 
causing  reduced  abomasal  function  or  perhaps  even  the 
physical presence of a capsule interfering with normal rumen 
function.
A few sheep reached peak FEC of 8600 eggs per gram by 
weeks two to four, but no sheep ever reached a FAMACHA© 
score of 3–5 requiring treatment for worms either during or 
TABLE 3: Summary of efficacy calculated over the length of the study.
Groups compared D 15 (13 April) D 30 (28 Apr) D 43 (11 May) D 59 (27 May) D 78 (15 June) D 99 (06 July)
Efficacy ICRC vs IUC -36.1 35.4 -97.7 -36.5 -88.9 -242.1
Efficacy ICRC vs ITC -503.6 -31 -43.5 -21 -0.5 -177.6
Efficacy BCRC vs BUC -36.3 51.4 23.6 23.6 59 79.5
Efficacy ITC vs IUC 83.6 24.7 31.2 18.4 1.8 64.4
Note: The efficacies are expressed in percentages.
D, study day since treatment on day 0; ICRC, individual (unpooled) egg per gram counts of controlled-release capsule treated sheep; IUC, individual (unpooled) egg per gram counts of untreated 
(negative) control group sheep; ITC, individual (unpooled) egg per gram counts of treated (positive) control group sheep; BCRC, bulk (pooled) egg per gram counts of controlled-release capsule 
treated sheep; BUC, bulk (pooled) egg per gram counts of untreated (negative) control group sheep
TABLE 4: Mean weight gains (kg) over the study period.
Treatment group N Mean Standard deviation Standard error 95% Confidence interval formean
Lower bound Upper bound
No treatment 85 5.1 1.5 0.2 4.7 5.4
Extender 100®a 99 4.1 1.8 0.2 3.8 4.5
Valbazen 15 4.5 1.6 0.4 3.7 5.4
Total 199 4.6 1.7 0.1 4.3 4.8
a, Has only 99 animals in sample as one animal was treated with a macrocyclic lactone because of Chrysomayia bezziana infection.Original Research
doi:10.4102/jsava.v84i1.1000 http://www.jsava.co.za
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after the trial. Furthermore, the median FAMACHA© score 
in all groups in this study was 1. It is believed that this could 
be explained by the farmer actively selecting for internal-
parasite-resilient  sheep  over  many  years.  Drenching  has 
been largely ineffective on this farm for many years due to 
resistance to virtually all of the active ingredients available 
until fairly recently. In addition, FAMACHA© scoring has 
been routinely employed since the emergence of resistance 
on the farm and is used with faecal egg counts to decide 
when to drench, if at all. All poor doers (generally due to 
high worm burdens and susceptibility to internal parasites) 
have been culled out of the flock. It is hypothesised that this 
strategy may have been responsible for the relatively quick 
reversion to moderate albendazole susceptibility of the H. 
contortus population.
Sheep in all groups in the trial showed a steady drop in faecal 
egg counts from mid-April until the end of the trial on 06 July 
(Figure 1 and Figure 2). This was attributed to a combination 
of: a reduction in the natural (field) challenge of H. contortus 
caused  by  cooler  average  daily  temperatures  in  autumn 
and early winter; protein supplementation prior to mating; 
development of natural immunity to the worms after exposure; 
shedding of worms; and H. contortus becoming hypobiotic as 
winter approached. A previous report (Sutherland et al. 1998) 
indicated that resistant strains of Ostertagia circumcinta and 
Trichostrongylus  colubriformis  established  infection  in  CRC-
treated animals and the humoral immune response to these 
parasites was not inhibited in CRC treated animals. Although 
this case involved a different parasite, it can be reported that 
that the zero EPG value was not different between CRC and 
negative control groups, which could indicate similar levels 
of natural immunity developing in CRC treated animals and 
negative controls. However, this effect is difficult to separate 
from the effect of hypobiosis, as mentioned above.
Conclusion
In this trial, the slow-release 100 day albendazole capsule 
Extender  100®  had  no  beneficial  effect  on  resistant  H. 
contortus parasite burdens as measured by faecal egg count 
and  FAMACHA©  scores,  as  well  as  on  weight  gain  and 
conception rate. 
Based on the results of this trial, the use of this product on 
farms with known severe albendazole resistance is probably 
contraindicated  as  it  will  possibly  exacerbate  the  existing 
anthelmintic  resistance  problem  by  selecting  for  resistant 
worms, without any positive benefit to the sheep or owner.
Acknowledgements
The authors thank the following persons: Mr B.M. Zazi and 
Mr  S.S.  Mandla  (SASO  laboratory  assistants,  Provincial 
Veterinary  Laboratory,  Queenstown,  South  Africa)  for 
processing and analysing faecal samples; Mr R.F. Blaine and 
staff of Wauldby Farm, Stutterheim, South Africa for all their 
effort, assistance and willingness to perform the trial on the 
sheep flock; Dr G.W. Akol (Manager, Laboratory services, 
Eastern  Cape  Department  of  Rural  Development  and 
Agrarian Reform, South Africa); Dr J. Van Wyk and Prof. G. 
Bath for advice and guidance over many years. Publication 
of this article was sponsored by the Eastern Cape and Karoo 
Branch of the South African Veterinary Association.
Competing interests
The authors declare that they have no financial or personal 
relationships that may have influenced them inappropriately 
in writing this article.
Authors’ contributions
A.D.F.  (Eastern  Cape  Department  of  Rural  Development 
and  Agrarian  Reform,  Provincial  Veterinary  Laboratory, 
Queenstown) was the project leader and was responsible for 
the experimental design, overseeing and/or performing all 
experimental work and writing the first draft manuscript. 
S.J.v.S.  (MSD  Malelane  Research  Unit,  Malelane)  made 
conceptual  contributions  and  expanded  the  manuscript, 
performed  the  literature  study  and  performed  statistical 
analysis of the data.
References
Bath, G.F., Malan, F.S. & Van Wyk, J.A., 1996, ‘The “FAMACHA” ovine anaemia guide to 
assist with the control of haemonchosis’, Proceedings of the 7th Annual Congress 
of the Livestock Health and Production Group of the South African Veterinary 
Association, Port Elizabeth, South Africa, 5–7 June 1996, p. 5. 
D, day; Ext 100 indiv, Extender 100® controlled-release capsule treated sheep; Neg ctr indiv, 
negative (untreated) control group sheep; Pos ctr indiv, positive (single oral albendazole 
dose) treated sheep
FIGURE 1: The arithmetic mean faecal egg count scores of individual animals 
(unpooled).
Study day
F
a
e
c
a
l
 
e
g
g
 
c
o
u
n
t
2000
1800
1600
1400
1200
1000
800
600
400
200
0
Ext 100 indiv
Neg ctr indiv
Pos ctr indiv
D0          D15           D20          D43          D59          D78         D109
Study day D0            D15          D20          D43          D59          D78         D109
1400
1200
1000
800
600
400
200
0
F
a
e
c
a
l
 
e
g
g
 
c
o
u
n
t
CRC Group
Negative control
D, day; CRC group, Extender 100® controlled-release capsule treated group
FIGURE 2: Mean bulk (pooled) faecal egg counts of two groups during the study. Original Research
doi:10.4102/jsava.v84i1.1000 http://www.jsava.co.za
Page 5 of 5
Dobson, R.J., Sangster, N.C., Besier, R.B. & Woodgate, R.G., 2009, ‘Geometric means 
provide a biased efficacy result when conducting a faecal egg count reduction 
test (FECRT)’, Veterinary Parasitology 161, 162–167. http://dx.doi.org/10.1016/j.
vetpar.2008.12.007, PMid:19135802
Fisher, A.D., 2013, Unpublished data in possession of the author. 
Fisher, M.A., Jacobs, D.E. & Jones, P.A., 1992, ‘Field evaluation of an albendazole 
intraruminal  capsule  against  benzimidazole-resistant  Haemonchus  contortus’, 
Veterinary  Record  130,  351–353.  http://dx.doi.org/10.1136/vr.130.16.351, 
PMid:1595176
Kelly,  G.A.,  Walkden-Brown,  S.W.  &  Kahn,  L.P.,  2012,  ‘No  loss  of  production  due 
to  larval  challenge  in  sheep  given  continuous  anthelmintic  treatment  via  a 
controlled release capsule’, Veterinary Parasitology 183, 274–283. http://dx.doi.
org/10.1016/j.vetpar.2011.07.033, PMid:21824729
Kruskal, W.H., Wallis, W.A., 1952, ‘Use of ranks in one-criterion variance analysis’, 
Journal of the American Statistical Association 47, 583–621. http://dx.doi.org/1
0.1080/01621459.1952.10483441
Le  Jambre,  L.F.,  Prichard,  P.K.,  Hennessy,  D.R.  &  Laby,  R.H.,  1981,  ‘Efficiency  of 
oxfendazole  administered  as  a  single  dose  or  in  a  controlled  release  capsule 
against benzimidazole-resistant Haemonchus contortus, Ostertagia circumcincta 
and Trichostrongylus colubriformis’, Research in Veterinary Science 31, 289–294. 
PMid:7342223
Little,  P.R.,  Hodge,  A.,  Maeder,  S.J.,  Wirtherle,  N.C.,  Nicholas,  D.R.,  Cox,  G.G.  & 
Conder,  G.A.,  2011,  ‘Efficacy  of  a  combined  oral  formulation  of  derquantel-
abamectin against the adult and larval stages of nematodes in sheep, including 
anthelmintic-resistant  strains’,  Veterinary  Parasitology  181,  180–193.  http://
dx.doi.org/10.1016/j.vetpar.2011.05.008, PMid:21684691
McKenna, P.B., 2006, ‘A comparison of faecal egg count reduction test procedures’, 
New Zealand Veterinary Journal 54, 202–203. http://dx.doi.org/10.1080/004801
69.2006.36697, PMid:16915344
Reinecke, R.K., 1983, Veterinary helminthology, Butterworth, Pretoria.
Sutherland, I.A., Leathwick, D.M., Green, R.S., Miller, C.M. & Brown, A.E., 1998, ‘The 
effect of continuous drug exposure on the immune response of lambs challenged 
with drug-susceptible or drug-resistant nematode larvae’, Veterinary Research 
Communications  22,  305–314.  http://dx.doi.org/10.1023/A:1006160718389, 
PMid:9778776
Van Wyk, J.A. & Bath, G.F., 2002, ‘The FAMACHA© system for managing haemonchosis 
in  sheep  and  goats  by  clinically  identifying  individual  animals  for  treatment’, 
Veterinary  Research  33,  509–529.  http://dx.doi.org/10.1051/vetres:2002036, 
PMid:12387487
Van Wyk, J.A., Malan, F.S. & Randles, J.L., 1997, ‘How long before resistance makes it 
impossible to control some field strains of Haemonchus contortus in South Africa 
with any of the modern anthelmintics?’, Veterinary Parasitology 70, 111–122. 
http://dx.doi.org/10.1016/S0304-4017(96)01147-8
Williamson,  J.F.,  1995,  ‘Parasitism  and  production  in  fleece-weight-selected  and 
control sheep’, New Zealand Journal of Agricultural Research 38, 381–387. http://
dx.doi.org/10.1080/00288233.1995.9513140
Wood, I.B., Amaral, N.K., Bairden, K., Duncan, J.L., Kassai, T., Malone, J.B. Jr., Pankavich, 
J.A., Reinecke, R.K., Slocombe, O., Taylor, S.M. & Vercruysse, J., 1995, ‘World 
Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second 
edition of guidelines for evaluating the efficacy of anthelmintics in ruminants 
(bovine, ovine, caprine)’, Veterinary Parasitology 58, 181–213.